← back to search

Gencay Hatiboglu

Heidelberg University · DE
Area of research
Pulmonary and Respiratory Medicine · Urology
Research interest
Research interests include Prostate Cancer Diagnosis and Treatment, Renal cell carcinoma treatment, Urinary Bladder and Prostate Research, and Prostate Cancer Treatment and Research.
h-index
26
citations
2,380
works
123
NIH funding
primary concept
Medicine
email

Recent publications

Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial
The Lancet 2025cited by 42position: middledoi
Durability of Functional Outcomes After MRI-Guided Transurethral Ultrasound Ablation of the Prostate
JU Open Plus 2023cited by 4position: firstdoi
Detecting and Locating the Site of Local Relapse Using 18F-PSMA-1007 Imaging After Primary Treatment of 135 Prostate Cancer Patients—Potential Impact on PSMA-Guided Radiation Therapy
Molecular Imaging and Biology 2022cited by 5position: middledoi
Mutations in TP53 or DNA damage repair genes define poor prognostic subgroups in primary prostate cancer
Urologic Oncology Seminars and Original Investigations 2021cited by 36position: middledoi
Single-Center Evaluation of Treatment Success Using Two Different Protocols for MRI–Guided Transurethral Ultrasound Ablation of Localized Prostate Cancer
Frontiers in Oncology 2021cited by 3position: firstdoi
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial
The Lancet Oncology 2020cited by 492position: middledoi
Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Cancer
The Journal of Urology 2020cited by 80position: middledoi
Magnetic resonance imaging‐guided transurethral ultrasound ablation in patients with localised prostate cancer: 3‐year outcomes of a prospective Phase I study
British Journal of Urology 2020cited by 23position: middledoi
High prevalence of DNA damage repair gene defects and TP53 alterations in men with treatment-naïve metastatic prostate cancer –Results from a prospective pilot study using a 37 gene panel
Urologic Oncology Seminars and Original Investigations 2020cited by 22position: middledoi
Prognostic and Predictive Value of Tumor-infiltrating Leukocytes and of Immune Checkpoint Molecules PD1 and PDL1 in Clear Cell Renal Cell Carcinoma
Translational Oncology 2019cited by 76position: middledoi
The Value of Prostate-specific Antigen Density for Prostate Imaging-Reporting and Data System 3 Lesions on Multiparametric Magnetic Resonance Imaging: A Strategy to Avoid Unnecessary Prostate Biopsies
European Urology Focus 2019cited by 59position: middledoi
Standardized Magnetic Resonance Imaging Reporting Using the Prostate Cancer Radiological Estimation of Change in Sequential Evaluation Criteria and Magnetic Resonance Imaging/Transrectal Ultrasound Fusion with Transperineal Saturation Biopsy to Select Men on Active Surveillance
European Urology Focus 2019cited by 44position: middledoi
Lamin‑B1 is a senescence‑associated biomarker in clear‑cell renal cell carcinoma
Oncology Letters 2019cited by 41position: middledoi
Recovery of pad-free continence in elderly men does not differ from younger men undergoing robot-assisted radical prostatectomy for aggressive prostate cancer
World Journal of Urology 2019cited by 28position: middledoi
Magnetic resonance imaging-guided transurethral ultrasound ablation of prostate tissue in patients with localized prostate cancer: single-center evaluation of 6-month treatment safety and functional outcomes of intensified treatment parameters
World Journal of Urology 2019cited by 16position: firstdoi
Correlation between genomic index lesions and mpMRI and 68Ga-PSMA-PET/CT imaging features in primary prostate cancer
Scientific Reports 2018cited by 36position: middledoi
Genomic features of renal cell carcinoma with venous tumor thrombus
Scientific Reports 2018cited by 33position: middledoi
Twelve-month prostate volume reduction after MRI-guided transurethral ultrasound ablation of the prostate
European Radiology 2018cited by 31position: middledoi
Prospective Single Center Trial of Next-Generation Sequencing Analysis in Metastatic Renal Cell Cancer: the MORE-TRIAL
Future Science OA 2018cited by 3position: middledoi
Complete bladder neck preservation promotes long-term post-prostatectomy continence without compromising midterm oncological outcome: analysis of a randomised controlled cohort
World Journal of Urology 2017cited by 40position: middledoi
Expression and Functional Characterization of the BNIP3 Protein in Renal Cell Carcinomas
Translational Oncology 2017cited by 20position: middledoi
Magnetic Resonance Imaging–Guided Transurethral Ultrasound Ablation of Prostate Tissue in Patients with Localized Prostate Cancer: A Prospective Phase 1 Clinical Trial
European Urology 2016cited by 96position: middledoi
Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneity
Nature Communications 2016cited by 79position: middledoi
Further reduction of disqualification rates by additional MRI-targeted biopsy with transperineal saturation biopsy compared with standard 12-core systematic biopsies for the selection of prostate cancer patients for active surveillance
Prostate Cancer and Prostatic Diseases 2016cited by 59position: middledoi
Acute Toxicity and Quality of Life in Patients With Prostate Cancer Treated With Protons or Carbon Ions in a Prospective Randomized Phase II Study—The IPI Trial
International Journal of Radiation Oncology*Biology*Physics 2016cited by 59position: middledoi
Intraoperative Computed Tomography Imaging for Navigated Laparoscopic Renal Surgery: First Clinical Experience
Journal of Endourology 2016cited by 40position: middledoi
Use of Surgical Navigation During Urologic Surgery
2016cited by 0position: middledoi
Ion Prostate Irradiation (IPI) – a pilot study to establish the safety and feasibility of primary hypofractionated irradiation of the prostate with protons and carbon ions in a raster scan technique
BMC Cancer 2014cited by 26position: middledoi
Localised prostate cancer treated with MRI-guided transurethral ultrasound ablation: phase I trial results
Cancer Imaging 2014cited by 3position: middledoi
Endogenous BTG2 expression stimulates migration of bladder cancer cells and correlates with poor clinical prognosis for bladder cancer patients
British Journal of Cancer 2013cited by 39position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Markus Hohenfellner · Chirurgische Universitätsklinik Heidelberg15 papers (2013–2022)Sascha Pahernik · Nuremberg Hospital11 papers (2013–2023)David Bonekamp · Heidelberg University9 papers (2016–2023)Heinz-Peter Schlemmer · German Cancer Research Center8 papers (2016–2023)Mathieu Burtnyk · Sunnybrook Health Science Centre7 papers (2014–2021)Matthias Roethke · Collaborative Group (United States)7 papers (2014–2023)Boris Hadaschik · Deutsche Gesellschaft für Urologie7 papers (2013–2018)Joanne Nyarangi‐Dix · Johannes Gutenberg University Mainz6 papers (2017–2021)Jan Philipp Radtke · German Cancer Research Center6 papers (2016–2021) · 6 papers (2014–2023)Joseph L. Chin · Clinique Mutualiste Chirurgicale6 papers (2014–2023)Robert Staruch · Southwestern Medical Center5 papers (2018–2021) · 5 papers (2014–2023)Timur H. Kuru · The University of Texas at Austin4 papers (2014–2018)Stephan Macher‐Goeppinger · Johannes Gutenberg University Mainz4 papers (2013–2019)Wilfried Roth · Johannes Gutenberg University Mainz4 papers (2016–2019)Doğu Teber · Städtisches Klinikum Karlsruhe4 papers (2013–2019) · 4 papers (2014–2023)Ionel Valentin Popeneciu · University Hospital Heidelberg4 papers (2016–2021)Georgi Tosev · University Hospital Heidelberg4 papers (2017–2019)